This paper compared the yield, size, purity, and protein expression levels of extracellular vesicles (EVs) isolated from plasma using three different methods. The levels of prostate specific antigen (PSA) positive EVs were compared between plasma from healthy individuals and those with prostate cancer.
Quality Assessment and Comparison of Plasma-Derived Extracellular Vesicles Separated by Three Commercial Kits for Prostate Cancer Diagnosis.
Pang B, Zhu Y, Ni J, Ruan J, Thompson J, Malouf D, Bucci J, Graham P, Li Y
Purpose
Conclusion
Particle size distribution and yield were dependent on isolation method with ExoQuick yielding the most particles but also those with the largest modal size, although overall appearance of the particles was similar. While all three kits yielded particles with CD81 and TSG101, CANX was only detected in particles isolated using qEV35 columns. Higher CD9/81/63 signals were obtained from EVs obtained using qEV35 columns and the ExoQuick Kit than using qEV70 columns, but those isolated with qEV70 columns displayed the highest purity and lowest lipoprotein and protein. Particle numbers were strongly to very strongly correlated to EV amount (CD9/81/63 intensity) using all three isolation methods but particle number and protein amount were only strongly correlated in EVs isolated using qEV70 columns. While PSA was detected on EVs isolated using all three kits, levels were comparable in healthy patients and those with prostate cancer. When isolation of the EVs was with qEV70 columns, a higher percentage of the EVs were PSA positive in healthy patients than prostate cancer patients but this was not found using the other isolation methods and total number of EVs was comparable between cancer patients and healthy controls.
Studies (1)
Purpose
This study compared the yield, size, purity, and protein expression levels of EVs isolated from plasma using three different methods. The levels of prostate specific antigen (PSA) positive EVs were compared between plasma from healthy individuals and those with prostate cancer. K2EDTA blood from six non-fasting patients with localized prostate cancer and six age and gender matched healthy individuals was centrifuged at 3000 rpm for 15 min at 4°C to obtain plasma within 2 h of collection. Plasma was transferred to new tubes and centrifuged at 2000 × g for 20 min followed by centrifugation of the supernatant at 10,000 × g for 20 min and filtration through a 0.22 μm pore Ultrafree centrifugal filter at 12,000 × g for 2 min. Plasma was stored at −80°C and subjected to ≤2 freeze-thaw cycles before EV isolation. EVs were isolated using the qEV35 and qEV70 size-exclusion columns with post-enrichments using an Amicon Ultra-4 10 KDa unit and the ExoQuick ULTRA Kit. Isolated EVs were stored at -80°C and subjected to ≤2 freeze-thaw cycles. EV concentration and size distribution were evaluated by nanoparticle tracking analysis. Protein levels were quantified using the Qubit Protein Assay Kit. EVs were further validated by immunoblotting using the Exo-Check Exosome Antibody Array. Lipoprotein contamination and EV quality were evaluated using Anti-ApoB and anti-EV surface marker (CD63, CD9, and CD81) conjugated magnetic beads and detected by flow cytometry. The morphology of the isolated EVs was investigated by cryogenic electron microscopy.
Summary of Findings
A higher number of particles per mL of plasma were obtained using the ExoQuick Ultra or qEV35 than the qEV70 columns (P<0.0001 and P<0.01, respectively). The modal particle size was dependent on the kit, with a mode size of 141.9 ± 12.5 nm using ExoQuick versus 120.6 ± 14.9 nm using qEV35 (P<0.001) and 127.7 ± 10.4 nm using qEV70 (P<0.05) columns. Particle size distribution curves were comparable for EVs isolated using the qEV35 and qEV70 size-exclusion chromatography columns for particles less than 130 nm but the qEV70 column yielded more particles >130 nm than the qEV35 column. In comparison, the ExoQuick columns yielded fewer particles <130 nm and more particles >130 nm than both SEC columns. The particles isolated using each of the three methods expressed CD81 and TSG101 but CANX was only detected in particles isolated using qEV35 columns. EM showed single vesicle, double vesicle, and multilayer vesicle EVs as well as very low-density lipoproteins (VLDL) isolated using each of the three methods. Higher CD9/81/63 signals were obtained from EVs obtained using qEV35 columns and the ExoQuick Kit than using qEV70 columns (P<0.001 and P<0.0001, respectively) but those isolated with qEV70 columns displayed the higher purity than those isolated using qEV35 columns or the ExoQuick Kit (P<0.05 and P<0.001, respectively) and the purity was higher using qEV35 columns than ExoQuick (P<0.01). Lipoprotein and protein contamination were lower in specimens isolated using qEV70 columns than qEV35 (P<0.01 and P<0.0001, respectively) or ExoQuick columns (P<0.0001 and P<0.01, respectively) and, as a result, the lipoprotein to EV ratio was higher in specimens obtained with qEV35 columns or the ExoQuick Kit than qEV70 columns (P<0.01 and P<0.0001, respectively) and with the ExQuick kit compared to qEV35 columns (P<0.001). Particle numbers were strongly correlated to EV amount (CD9/81/63 intensity) when isolation was with qEV70 columns (R2=0.8774, P<0.0001) and very strongly correlated when isolated with ExoQuick (R2=0.9186, P<0.0001) or qEV35 columns (R2=0.9557, P<0.0001) but particle number and protein amount were only strongly correlated in EVs isolated using qEV70 columns (R2=0.9875, P<0.0001). While PSA was detected on EVs isolated using all three kits, levels were comparable in healthy patients and those with prostate cancer. When isolation of the EVs was with qEV70 columns, a higher percentage of the EVs were PSA positive in healthy patients than prostate cancer patients (P<0.05) but this was not found using the other isolation methods and total number of EVs was comparable between cancer patients and healthy controls.
Biospecimens
FluidPlasmaFluidBloodPreservation Types
FrozenDiagnoses
NeoplasticCarcinomaNormalPlatforms
ProteinFluorometryCell count/volumeLight scatteringCell count/volumeElectron microscopyMorphologyElectron microscopyProteinImmunoassayProteinFlow cytometryCell count/volumeFlow cytometryPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition HealthyProstate cancerAnalyte Extraction and Purification Analyte isolation method ExoQuick Ultra kitqEV35 columnqEV70 column